We use optical tweezers to perform stretching experiments on DNA molecules when interacting with the drugs daunomycin and ethidium bromide, which intercalate the DNA molecule. These experiments are performed in the low-force regime from zero up to 2 pN. Our results show that the persistence length of the DNA-drug complexes increases strongly as the drug concentration increases up to some critical value. Above this critical value, the persistence length decreases abruptly and remains practically constant for larger drug concentrations. The contour length of the molecules increases monotonically and saturates as drugs concentration increases. Measured intercalants critical concentrations for the persistence length transition coincide with reported values for the helix-coil transition of DNA-drug complexes, obtained from sedimentation experiments.
I. INTRODUCTION
DNA-drug interactions have been much studied along the past years. An important motivation for these studies is the fact that many of the studied drugs are used for treatment of human diseases, particularly, in cancer chemotherapy.
Single molecule stretching experiments using optical tweezers have yielded a great amount of information about DNA-protein and DNA-drug interactions [1, 2, 3, 4, 5, 6] .
Recently, we studied the interaction between psoralen and DNA when illuminated with ultraviolet light A (UVA). Psoralen is a drug used to treat some skin diseases, like psoriasis and vitiligo. This drug intercalates the DNA molecule and can form covalent linkages with the thymines if the complex is illuminated with ultraviolet light, modifying drastically its elasticity and impeding the DNA replication and transcription. The persistence length of the DNA-psoralen complexes formed after UVA illumination were measured in [7] .
Daunomycin and ethidium bromide (EtBr) are other examples of drugs which intercalate the DNA molecule and can modify its elasticity, depending on the drug concentration. Both drugs unwind the DNA double helix when intercalating [8] . Daunomycin is an anthracycline antibiotic used in the treatment of various cancers. It inhibits DNA replication and transcription when intercalating, impeding cell duplication [9] . Ethidium bromide (EtBr) is commonly used as a non-radioactive marker for identifying and visualizing nucleic acid bands in electrophoresis and in other methods of nucleic acid separation.
Several works have reported different results for the effects of these drugs on the entropic elasticity of DNA molecules. In those works, the measured parameter used to study elasticity modifications is the persistence length of the DNA-drug complex. Smith et al. [2] report that ethidium bromide does not modify the elasticity of the DNA molecule, only increasing its contour length by ∼40%. Tessmer et al. [10] report that ethidium bromide causes a large increase in the contour length and a decrease in the persistence length of the complex for 1 µM of the drug, and at lower concentrations, an increase in both persistence and contour lengths. Recently, Sischka et al. [11] report the value of 28.1 nm for the persistence length of DNA-daunomycin complexes and 20.7 nm for DNA-EtBr complexes, smaller than the bare DNA persistence length of about 50 nm. The authors have used in this work a concentration of 1 µM for both drugs, and a DNA concentration of 15 pM. In the present work, in order to clearly establish the effect of these intercalating drugs on the persistence length of the DNA 2 complexes, we performed stretching experiments at various drugs concentrations, from zero up to saturation of the complexes. We show that the values obtained for the persistence length depend strongly on the concentration ratio between drug and DNA base pairs. Our results show that the persistence length of the complexes increases as we increase the drug concentration until certain critical concentration is reached. Above this critical concentration the persistence length decreases abruptly and remains practically constant for larger drug concentrations.
II. EXPERIMENTAL PROCEDURE
To measure the persistence and contour length of DNA molecules and DNA-drug complexes, we use optical tweezers [1, 2, 3, 4, 5, 6] and intensity autocorrelation spectroscopy [12] .
The samples consist of λ-DNA molecules in a PBS pH 7.4 with [NaCl] = 140 mM solution.
We attach one end of the molecule to a microscope coverslip, and the other end is attached to a polystyrene bead. To do this, we use the procedure described in [13] . We add the drug in the sample immediately before the measurements. The DNA concentration used in all experiments was C DN A = 6.81 µg/mL, which corresponds to a base pairs concentration of
Our optical tweezers is mounted in a Nikon TE300 microscope with an infinite corrected objective (100X, N.A. = 1.4). The trapping laser is an infrared (IR) laser with λ = 832 nm (SDL, 5422-H1). The optical tweezers is used to trap the polystyrene bead attached to the end of the DNA molecule, so we can manipulate and stretch the DNA molecule.
In addition, we use a He-Ne laser (λ = 632.8 nm) as the scattering probe. The backscattered light by the polystyrene bead is collected by a photodetector, which delivers pulses to a digital correlator. We, then, obtain the autocorrelation function of the backscattered light, which allows us to determine the stiffness of the optical trap, due to the Brownian motion of the trapped bead.
The next step in the experimental procedure is to obtain the force versus extension curves for the DNA molecules and DNA-drug complexes. To do this, we use the optical tweezers to trap the bead with the DNA while pulling the microscope slide, stretching the DNA.
The backscattered light is collected while stretching the DNA. From the backscattered light intensity one obtains the displacement of the trapped bead in relation to its equilibrium position, and by multiplying it times the tweezers' stiffness, the force exerted by the DNA molecule while it is stretched is obtained. The details about our experimental setup and experimental procedure can be found in [7, 12] .
Finally, with the force versus extension curves, we use the approximate expression derived by Marko and Siggia (Eq. 1) [14] to obtain the persistence and contour length of the DNA molecules and DNA-drug complexes,
where z is the DNA molecule end-to-end distance, k B is the Boltzmann constant, T is the absolute temperature, A is the DNA persistence length and L is the DNA contour length. 
III. RESULTS AND DISCUSSION
In this section we show the results obtained for the two drugs used: daunomycin and ethidium bromide.
A. Daunomycin
We have performed experiments with DNA-daunomycin complexes for several drug concentrations. In Fig. 2 we show the persistence length (A) of the complexes as a function of total daunomycin concentration (C D ) for fixed DNA base pairs concentration of C bp = 11 µM. We denote by C D the total daunomycin concentration used to prepare the sample, which is the sum of both the bounded to DNA and the free drug concentration in solution.
The point which the drug concentration is zero corresponds to the drug-free DNA situation with A = 50 nm. Also, we can estimate the exclusion parameter n (number of total base pairs divided by the number of total intercalated drug molecules) from our experimental data. The average value of the contour length for DNA-daunomycin complexes obtained when using a saturated concentration of the drug increases about 27% relative to drug-free DNA contour length (16.5 µm). This means that when all possible drug molecules are intercalated, the DNA increases its contour length by 4.5 µm. Knowing that each intercalated daunomycin molecule increases the contour length of the complex by 0.31 nm [8] , we determine the total number of intercalated daunomycin molecules, which is around 14500. Finally, the exclusion parameter can be obtained by dividing the number of base pairs of the λ-DNA (48500) by the number of total intercalated drug molecules (14500). We obtain n = 3.3, in good agreement with the value 3.5 reported in [9] .
For comparison purposes, Fig. 3 shows two force versus extension curves (normalized by the contour length) for two daunomycin concentrations, before and after the transition. The data points in this figure are smoothed for better visualization, i. e., Brownian fluctuations are averaged out.
B. Ethidium Bromide (EtBr)
The behavior of the persistence length as a function of the drug concentration for DNAEtBr complexes is very similar to the DNA-daunomycin complexes. The difference is that in this case the transition occurs at a lower drug concentration (see Fig. 4 ) for the same DNA base pairs concentration C bp = 11 µM. The maximum value measured for the persistence length of DNA-EtBr complexes is ∼ 150 nm, at the critical concentration C critical E = 3.1 µM.
The contour length increases monotonically from 16.5 ± 1 µm up to the saturation value of 23 ± 1 µm. Again, these values for the contour lengths are averages over many different molecules.
Repeating the same calculation for the exclusion parameter of EtBr, which increases the DNA contour length by 0.34 nm per intercalated molecule [11] , we obtain n = 2.5, in reasonable agreement with the value 2.01 reported in [18] .
C. Equilibrium binding constants
In our experiments we control the total drug concentration C T and the total concentration of DNA base pairs C bp . To discuss the elastic properties of the DNA complex formed the important parameter to consider is the ratio r between the concentration of bounded drug (C b ) per concentration of DNA base pairs (C bp ). In order to obtain r, the binding of molecules to DNA is analyzed using the neighbor exclusion model [9] . A closed form for this model was obtained by McGhee and von Hippel [19] and can be expressed by the equation
where r is ratio between the concentration of bounded drug (C b ) per concentration of DNA base pairs (C bp ), C f is the concentration of free drug (not bounded), K i is the intrinsic binding constant and n is the exclusion parameter in base pairs. For a more detailed discussion about the neighbor exclusion model, see [19] .
The concentration of free drug (C f ) can be simply related with the concentration of bounded drug (C b ) and the total drug concentration (C T ) through the equation
Using Eq. 2 and 3 with the determined exclusion parameter (n = 3.3), the intrinsic binding constant reported in [9] for daunomycin,
, and the concentration of DNA base pair used in our experiments (C bp = 11 µM), we can determine the critical ratio r c , which we define as the value of r at the abrupt transition for the value of the persistence length. We then obtain the value r c = 0.248.
Similarly, for EtBr, we use the parameters n = 2.5, [20] , and C Force as a function of extension for a drug-free DNA molecule. By fitting this curve with Eq. 1, we determine the persistence length A = 50 ± 3 nm and the contour length L = 16.5 ± 1 µm. Persistence length of DNA-EtBr complexes as a function of drug concentration for fixed DNA concentration (C bp = 11 µM). Here, the transition occurs at a lower drug concentration.
The maximum value measured for the persistence length of DNA-EtBr complexes is ∼ 150 nm, at the critical concentration C critical E = 3.1 µM.
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